Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGolechha, Mahaveer-
dc.contributor.authorBhatia, Jagriti-
dc.contributor.authorArya, Dharamvir Singh-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.description.abstractThe cognitive impairment seen in epileptics may be a consequence of either the underlying epileptogenic process alone or it could manifest on account of the use of antiepileptic drugs that cause cognitive impairment as an adverse effect or both. Thus, there is a need for drugs that can suppress epileptogenesis without contributing to or , if possible, by acting to prevent the development of cognitive impairment. Emblica officinalis, an Indian medicinal plant, has marked antioxidant property. The effect of seven days pretreatment of 300, 500 and 700 mg/kg doses of hydroalcoholic extract of E. officinalis (HAEEO) administered intraperitoneally to rats was evaluated on pentylenetetrazole (PTZ) induced seizures, cognitive deficit and oxidative stress markers viz malondialdehyde (MDA) and glutathione. The 500 and 700 mg/kg ip doses of HAEEO completely abolished the generalized tonic seizures and also improved the retention latency in passive avoidance task. Further, HAEEO dose-dependently ameliorated the oxidative stress induced by PTZ. These findings suggest the potential of HAEEO to be used as an adjuvant to treatment with antiepileptic drugs.en_US
dc.sourceIJEB Vol.48(05) [May 2010]en_US
dc.subjectCognitive impairmenten_US
dc.subjectEmblica officinalisen_US
dc.subjectOxidative stressen_US
dc.titleHydroalcoholic extract of Emblica officinalis Gaertn. affords protection against PTZ-induced seizures, oxidative stress and cognitive impairment in ratsen_US
Appears in Collections:IJEB Vol.48(05) [May 2010]

Files in This Item:
File Description SizeFormat 
IJEB 48(5) 474-478.pdf48.8 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.